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OR- Odds ratioMETHODS: Data on childhood and adult environmental
exposures (including, among others, sibship size, day care, pets,
farm environment, and smoking), infant diet (including breast-
feeding and timing of introduction to infant formula and solids),
and demographic characteristics were collected from 2196
school-age children and 2185 adults completing an extensive
questionnaire and blood sampling in the cross-sectional pan-
European EuroPrevall project. Multivariable logistic regression
was applied to determine associations between the predictor
variables and sensitization to foods commonly implicated in
food allergy (specific IgE ‡0.35 kUA/L). Secondary outcomes
were inhalant sensitization and primary (nonecross-reactive) FS.
RESULTS: Dog ownership in early childhood was inversely
associated with childhood FS (odds ratio, 0.65; 95% CI, 0.48-
0.90), as was higher gestational age at delivery (odds ratio, 0.93
[95% CI, 0.87-0.99] per week increase in age). Lower age and
male sex were associated with a higher prevalence of adult FS
(odds ratio, 0.97 [95% CI, 0.96-0.98] per year increase in age,
and 1.39 [95% CI, 1.12-1.71] for male sex). No statistically
significant associations were found between other evaluated
environmental determinants and childhood or adult FS, nor
between infant diet and childhood FS, although early
introduction of solids did show a trend toward prevention of FS.
CONCLUSIONS: Dog ownership seems to protect against
childhood FS, but independent effects of other currently
conceived environmental and infant dietary determinants on FS
in childhood or adulthood could not be confirmed.  2020
The Authors. Published by Elsevier Inc. on behalf of the
American Academy of Allergy, Asthma & Immunology. This is
an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/). (J Allergy Clin
Immunol Pract 2020;8:3074-83)
Key words: Food sensitization; Food allergy; Inhalant sensiti-
zation; Predictors; Risk factors; Early-life exposures; Environ-
ment; Infant diet; Dog; Europe
INTRODUCTION
Prevalence estimates of IgE sensitization to foods range from
11% to 29% in 7- to 10-year-old children and from 7% to 24%
in adults across various European countries.1,2 Several studies
indicate that the prevalence of food sensitization (FS) in children
and adults is rising.3-7 The geographical variation in the preva-
lence of FS in children and adults of comparable genetic back-
ground, and the proposed increase in FS prevalence over time,
suggest an effect of environmental factors.8
Although FS does not invariably lead to food allergy (FA), it is
a prerequisite, and an objective end point that can feasibly be
obtained for multiple foods in a large group of participants.
Studies investigating environmental predictors for FS are scarce.
Some previous studies report a protective effect of certain envi-
ronmental determinants on FS in children, such as younger
maternal age at delivery,9 higher number of previous pregnan-
cies,10 exposure to a farm environment,10,11 or having childhoodpets (dogs or cats).11 Determinants related to infant diet also may
be relevant. Vitamin D insufficiency and late introduction of
solid foods, for example, have been associated with an increased
likelihood of FS.12-14 In adults, a link between the use of antacids
and increased FS has been proposed.15 Most studies in adults,
however, tend to focus on inhalant sensitization (IS) or other
atopic diseases as outcomes.16,17 As part of the European
Community Respiratory Health Survey, Svanes et al performed
extensive analyses on the effect of a multitude of childhood
environmental determinants on adult sensitization to inhalant
allergens, and found a protective effect of increasing family size,
bedroom sharing, and the presence of a dog in the childhood
home.17 Studies on this scale, which include multiple suggested
risk factors and allow for mutual adjustment, are not yet available
for the outcome FS or FA. Such studies are key to helping us
understand differences in prevalence and time trends between
and within populations.8
This gap in knowledge led to the current study, in which the
primary aim was to investigate how environmental, dietary, and
demographic determinants are associated with sensitization to
foods that are commonly consumed across Europe and
frequently implicated in FA. The focus was on early-life events
and exposures, and the outcome was assessed in both children
and adults, using data collected from all across Europe in a
standardized manner during the European Unionefunded
EuroPrevall project. Secondary outcomes included IS and pri-
mary (nonecross-reactive) FS, to determine whether there are
differences between predictors for FS and IS, the latter of which
was the focus of previous studies in adult populations.17
METHODS
Study design, setting, and subjects
A full description of the methodology of the EuroPrevall study, a
cross-sectional cohort study with a case-control design nested within,
is available elsewhere.18 In the current study, we included randomly
sampled children (7-10 years) and adults (20-54 years) from the
general population of Athens (Greece), Lodz (Poland), Madrid
(Spain), Reykjavik (Iceland), Utrecht (The Netherlands), Zurich
(Switzerland), and Vilnius (Lithuania), who completed phase I (a
short screening questionnaire) and phase II (a detailed questionnaire,
and blood sampling for detection of IgE against 24 common food
allergens [termed priority foods] and 6 common inhalant allergens [as
summarized in Online Repository Methods on data collection in this
article’s Online Repository at www.jaci-inpractice.org]). All phase I
participants who reported symptoms to 1 or more of the 24 priority
foods (cases) and a random sample of phase I participants who re-
ported no symptoms to these foods (controls) were invited for phase
II. All data were collected between 2007 and 2009 for children, with
a median time interval of 5 months between phase I and II; and
between 2006 and 2009 for adults, with a median time interval of 8
months. The local ethical committees of all participating centers gave
approval for this study, and informed consent was obtained from all
participants.
Data collection
The primary outcome, FS, was defined as positive serology
(specific IgE  0.35 kUA/L) to at least 1 of the 24 selected foods. IS
was considered present if a subject was sensitized to at least 1 of the 6
selected inhalant allergens. Primary FS, defined as sensitization
occurring through true plant- or animal-derived food allergens,
rather than through pollen inhalant allergens cross-reacting
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microarray assay (see Figure E1 in this article’s Online Repository at
www.jaci-inpractice.org). The overlap between the various outcome
variables is depicted in Figure E2 in this article’s Online Repository
at www.jaci-inpractice.org.
Information on determinants was extracted from answers to the
EuroPrevall phase II questionnaire (see Figures E3 and E4 in this
article’s Online Repository at www.jaci-inpractice.org). In addition
to the childhood environmental factors that were investigated for
both adults and children, infant dietary factors were taken into ac-
count for children, and adult environmental factors for adults.
Childhood environmental determinants were investigated for expo-
sure before the age of 2 years for children and before the age of 5
years for adults. To give a complete overview, demographic factors
were also assessed. More details on data collection are available in
this article’s Online Repository at www.jaci-inpractice.org.
Data analysis
As an initial exploration, differences between subjects with and
without FS were examined using the c2 test for categorical variables
and the 2-sample t test for continuous variables. Univariable logistic
regression was performed to assess crude associations between each
individual determinant and FS (crude odds ratios [ORs]). Multivari-
able logistic regression including all determinants was then applied to
obtain the independent contribution of the determinants to FS
(adjusted ORs). Details on missing data are available from Table E1 in
this article’s Online Repository at www.jaci-inpractice.org. To ensure
optimal power in the multivariable analysis and potentially reduce
bias, multiple imputation was performed using fully conditional
specification (20 imputations, 20 iterations), for which all variables in
Table E1 were included as covariates. Because it is known that the
prevalence of FS is variable between countries,1,2 all analyses were
controlled for center by adding center as a categorical covariate in the
model. To better understand the independent contribution of the
various determinants, a stepwise approach to model building was
chosen. In model I, multivariable analysis was performed with only
demographic factors. In model II, childhood environmental de-
terminants were added. In model III, infant dietary determinants were
added for children, and adult environmental determinants for adults.
To observe how the association between the determinants and FS
changed on adding comorbidity with overlapping pathophysiological
mechanisms, we performed additional analyses. First comorbid
atopy (asthma, allergic rhinitis, or atopic dermatitis, or at least 1 of
these 3 diseases in first-degree relatives, or parental FA [for the pe-
diatric population]), and then coexisting IgE sensitization to inhalant
allergens, was incorporated into model III.
To evaluate whether predictors for FS differ from predictors for IS
and primary FS, and enable comparison with earlier studies
regarding factors associated with sensitization, we also fitted model
III for these outcomes.
Analyses were conducted with SPSS version 25 (IBM Corpora-
tion, Armonk, NY). P values less than .05 were considered statisti-
cally significant.
RESULTS
Of the 2326 children and 2256 adults completing the phase II
questionnaire, the 2196 children and 2185 adults with available
food serology were evaluated in this study. There were no dif-
ferences in age or sex between those subjects who did and who
did not complete phase II. In subjects who did complete phase
II, subjects with available serology appeared somewhat morelikely to report symptoms to (priority foods) and were more
likely to be male, than subjects with missing serology results, but
no other remarkable differences were observed in demographic
characteristics or allergic comorbidities (see Table E2 in this ar-
ticle’s Online Repository at www.jaci-inpractice.org).
Respectively 494 children and 441 adults were sensitized to at
least 1 of the priority foods. The median age of the children was
8.9 years in both those with and without FS, and respectively
50.8% and 49.6% were males (Table I). The food-sensitized
adults had a median age of 35.3 years and 49.0% were males,
whereas the nonsensitized adults had a median age of 39.2 years
and 41.1% were males (Table II). Data on all determinants were
complete in 76.5% of the children and 82.2% of the adults; in
the rest, missing values on 1 or more of the determinants were
estimated by multiple imputation.
Children: Crude associations between demographic,
childhood environmental, and infant dietary
determinants and FS
Table I presents the results of univariable analyses in children.
No significant associations between demographic factors, age,
sex, and parental level of education and FS in childhood were
found. Lower gestational age, lower birth weight, and shorter
length at birth tended to increase the likelihood of FS (Table I).
Comorbid atopy, parental FA, and IS also showed strong positive
associations with FS.
Many childhood environmental factors demonstrated signifi-
cant inverse associations with FS, specifically having more sib-
lings, having older siblings, day care attendance before the age of
2 years, and having a pet dog before the age of 2 years.
Regarding dietary determinants, breast-feeding for longer than
6 months was inversely associated with FS, compared with
breast-feeding for less than 6 months. Breast-feeding was not
necessarily exclusive. Use of infant formula, which could be
either a replacement of or complementary to breast-feeding, was
positively associated with FS, especially hypoallergenic infant
formula. In subjects who received infant formula, a trend was
suggested where the younger infant formula was introduced, the
less likely FS became. A similar trend was observed for solid food
introduction.
Independent predictors of FS in children
In multivariable analyses, gestational age was the only de-
mographic determinant that remained significantly associated
with FS in childhood (Table III). The longer the pregnancy, the
lower the chance of FS in the child (OR, 0.93 [95% CI, 0.87-
0.99] per week of pregnancy duration). Of the childhood envi-
ronmental determinants, having a pet dog before the age of 2
years was still significantly inversely associated after multivariable
adjustment (OR, 0.65 [95% CI, 0.48-0.90]). Of the infant di-
etary determinants, use of hypoallergenic infant formula main-
tained a positive association with childhood FS (OR, 1.51 [95%
CI, 1.06-2.15]).
Adjustment for comorbid atopy did not result in relevant
changes to the associations obtained in model III (see Table E3
in this article’s Online Repository at www.jaci-inpractice.org).
Subsequent correction for coexisting IS resulted in male sex
becoming significantly inversely associated with FS (OR, 0.64
[95% CI, 0.49-0.84]) and attenuated the associations between
having a pet dog before the age of 2 years and use of hypoal-
lergenic infant formula and FS in childhood, suggesting that
TABLE I. Characteristics of children and crude associations with FS
Variable Sensitized (N [ 494) Not sensitized (N [ 1702) P Crude OR (95% CI)
Demographic characteristic
Age (y), mean  SD 8.97  0.98 8.88  0.96 .16 1.09 (0.98-1.21)
Sex
Male 251 (50.8) 845 (49.6) .65 1.05 (0.86-1.28)
Female 243 (49.2) 857 (50.4)
Highest level of education of parents
High 206 (41.7) 732 (43.0) .60 0.95 (0.77-1.16)
Low 288 (58.3) 969 (57.0)
Gestational age (wk), mean  SD 39.16  2.30 39.48  1.93 <.001 0.93 (0.89-0.97)
Birth weight (g), mean  SD 3344.27  561.28 3398.98  600.48 .07 0.98 (0.97-1.00) per 100 g
Birth length (cm), mean  SD 51.11  3.27 51.57  3.38 .01 0.96 (0.93-0.99)
Childhood environment
Maternal age (y), mean  SD 29.75  5.19 29.67  5.54 .78 1.00 (0.98-1.02)
No. of siblings
0 97 (19.7) 302 (17.8) .05 Reference
1 247 (50.2) 859 (50.6) 0.90 (0.69-1.18)
2 118 (24.0) 368 (21.7) 1.00 (0.73-1.36)
3 or more 30 (6.1) 169 (10.0) 0.55 (0.35-0.86)
No. of older siblings
0 277 (56.3) 857 (50.5) .02 Reference
1 154 (31.3) 591 (34.8) 0.81 (0.64-1.01)
2 51 (10.4) 175 (10.4) 0.90 (0.64-1.26)
3 or more 10 (2.0) 10 (2.0) 0.41 (0.20-0.77)
Bedroom sharing with other children* 135 (27.3) 493 (29.1) .45 0.92 (0.73-1.15)
Bedroom sharing with older children* 118 (23.9) 428 (25.2) .56 0.93 (0.74-1.18)
Day care attendance* 175 (35.4) 698 (41.1) .02 0.79 (0.64-0.97)
Farm environment* 2 (0.4) 8 (0.5) >.99 0.86 (0.13-3.45)
Inner-city environment* 212 (42.9) 741 (43.5) .81 0.97 (0.80-1.19)
Pet dog* 65 (13.2) 429 (86.8) .01 0.67 (0.50-0.89)
Pet cat* 79 (16.0) 280 (16.5) .80 0.97 (0.73-1.26)
Serious respiratory tract infection* 133 (26.9) 424 (24.9) .37 1.11 (0.88-1.39)
Use of antibiotics* 296 (59.9) 1025 (60.3) .88 0.98 (0.80-1.21)
Maternal smoking during pregnancy 63 (12.8) 25 3 (14.9) .23 0.84 (0.62-1.12)
Maternal smoking since birth 149 (30.2) 528 (31.1) .70 0.96 (0.77-1.19)
Paternal smoking since birth 201 (40.7) 710 (41.8) .67 0.96 (0.78-1.17)
Reflux medication in last 6 mo 3 (0.6) 17 (1.0) .42 0.61 (0.14-1.81)
Infant diet
Vitamin D supplementation* 374 (80.4) 1324 (82.3) .35 0.88 (0.68-1.15)
Breast-feeding duration
Never 51 (10.4) 173 (10.3) .07 Reference
4 mo 173 (35.3) 521 (31.1) 1.13 (0.79-1.62)
4-6 mo 80 (16.3) 237 (14.1) 1.15 (0.77-1.72)
>6 mo 186 (38.0) 745 (44.5) 0.85 (0.60-1.21)
Cow’s milk infant formula 282 (57.9) 982 (58.2) .90 0.99 (0.81-1.21)
Soy milk infant formula 38 (7.8) 110 (6.5) .31 1.22 (0.82-1.77)
Hypoallergenic infant formula 126 (25.9) 286 (17.0) <.001 1.71 (1.34-2.17)
Age start infant formula
Never 91 (18.7) 430 (25.6) .02 Reference
0-4 mo 225 (46.3) 742 (44.2) 1.43 (1.10-1.89)
4-6 mo 61 (12.6) 188 (11.2) 1.53 (1.06-2.21)
6-11 mo 81 (16.7) 253 (15.1) 1.51 (1.08-2.12)
11 mo 28 (5.8) 66 (3.9) 2.00 (1.21-3.27)
(continued)
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TABLE I. (Continued)
Variable Sensitized (N [ 494) Not sensitized (N [ 1702) P Crude OR (95% CI)
Age of introduction of solid foods
0-4 mo 76 (15.7) 342 (20.6) .04 Reference
4-6 mo 226 (46.8) 738 (44.4) 1.38 (1.04-1.85)
6-11 mo 133 (27.5) 463 (27.8) 1.29 (0.95-1.78)
11 mo 48 (9.9) 120 (7.2) 1.80 (1.18-2.73)
Comorbid atopy 26 (5.3) 189 (11.3) <.001 2.28 (1.52-3.55)
Parental FA 128 (29.0) 377 (24.8) .07 1.24 (0.98-1.57)
Pollen sensitization† 325 (66.7) 178 (10.6) <.001 16.89 (13.26-21.62)
IS overallz 368 (75.6) 335 (20.0) <.001 12.39 (9.78-15.78)
Center
Zurich 93 (18.8) 211 (12.4) <.001 2.71 (1.89-3.89)
Madrid 82 (16.6) 196 (11.5) 2.57 (1.78-3.73)
Athens 40 (8.1) 115 (6.8) 2.14 (1.36-3.33)
Utrecht 102 (20.6) 296 (17.4) 2.12 (1.50-3.00)
Lodz 83 (16.8) 370 (21.7) 1.38 (0.97-1.97)
Vilnius 30 (6.1) 121 (7.1) 1.52 (0.93-2.44)
Reykjavik 64 (13.0) 393 (23.1) Reference
Results presented in n (%) unless otherwise specified. Bold indicates statistical significance (P < .05).
*Before the age of 2 y.
†IgE sensitization to birch, grass, mugwort, or parietaria.
zIgE sensitization to pollen, cat, or house-dust mite.
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(Table E3). The association between pet dog and FS remained
significant.Adults: Crude associations between demographic,
childhood, and adult environmental determinants
and FS
Table II presents the results of univariable analyses in adults.
Of the demographic factors, younger age and male sex were
significantly positively associated with FS, as were comorbid
atopy and IS.
Analyses of childhood environmental determinants in adults
showed a significant inverse association between having more
siblings, sharing a bedroom with other or older children before
the age of 5 years, and growing up on a farm before the age of
5 years and FS in adulthood (Table II). In contrast to the
findings in children, day care attendance before the age of 5
years was shown to significantly increase the likelihood of
adult FS.
Of the adult environmental determinants, ever having had a
food-related occupation was associated with a lower risk of FS.Independent predictors of FS in adults
Only the demographic factors age and sex remained signifi-
cantly associated with adult FS after multivariable adjustment
(Table III), yielding an OR of 0.97 (95% CI, 0.96-0.98) per year
increase in age and an OR of 1.39 (95% CI, 1.12-1.71) for male
sex. Multivariable analyses revealed no significant associations
between childhood or adult environmental determinants and FS
in adults.
Addition of comorbid atopy and subsequently IS to the model
did not notably change any of the observed associations
(Table E3).Secondary outcomes: Independent predictors of
sensitization to inhalant allergens and primary food
allergens
Table E4 in this article’s Online Repository at www.jaci-
inpractice.org facilitates comparison of predictors for FS, as dis-
cussed above, with predictors of the secondary outcomes, IS and
primary FS.
In children, the results pertaining to IS were generally similar to
those related to FS. Noticeable exceptions were that bedroom
sharing with other children before the age of 2 years and growing
up in a farm environment showed stronger inverse associations
with IS, the former of which reached statistical significance. Also,
although sex was not associated with FS, male sex was significantly
positively associated with IS. Regarding primary FS, no particular
differences in predictors were found compared with overall FS.
In adults, it was noteworthy that where there were no sig-
nificant associations between the childhood environmental de-
terminants and FS in adulthood, there was a significant inverse
association between growing up in a farm environment or with a
pet cat before the age of 5 years and IS. Furthermore, increasing
maternal age was significantly associated with a higher risk of IS.
Adjustment for comorbid atopy attenuated the protective effect
of cat ownership, but not that of farm or maternal age, which
suggests some reverse causality in the association between cat
ownership and IS.
Regarding the outcome primary FS, bedroom sharing with
older children before the age of 5 years was found to be inversely
associated, and smoking in adulthood significantly increased the
likelihood of primary FS in adults.
DISCUSSION
Summary of findings
Until now, no study existed in which the main postulated
environmental and infant dietary risk factors for FA were eval-
uated collectively in multivariable analysis, especially not all over
TABLE II. Characteristics of adults and crude associations with FS
Variable Sensitized (N [ 441) Not sensitized (N [ 1744) P Crude OR (95% CI)
Demographic characteristic
Age (y), mean  SD 36.10  9.35 38.89  9.52 <.001 0.97 (0.96-0.98)
Sex
Male 216 (49.0) 716 (41.1) <.001 1.38 (1.12-1.70)
Female 225 (51.0) 1028 (58.9)
Level of education
High 285 (64.6) 1151 (66.0) .59 0.94 (0.76-1.17)
Low 156 (35.4) 593 (34.0)
Childhood environment
Maternal age (y), mean  SD 28.60  5.59 28.03  5.90 .07 1.02 (1.00-1.03)
No. of siblings
0 32 (7.3) 128 (7.4) .01 Reference
1 169 (38.7) 582 (33.5) 1.16 (0.77-1.80)
2 122 (27.9) 428 (24.6) 1.14 (0.74-1.79)
3 or more 114 (26.1) 601 (34.6) 0.76 (0.50-1.19)
No. of older siblings
0 182 (41.6) 697 (40.1) .39 Reference
1 141 (32.3) 536 (30.8) 1.01 (0.79-1.29)
2 70 (16.0) 269 (15.5) 1.00 (0.73-1.35)
3 or more 44 (10.1) 237 (13.6) 0.71 (0.49-1.01)
Bedroom sharing with other children* 236 (53.5) 1058 (60.7) .01 0.74 (0.60-0.92)
Bedroom sharing with older children* 134 (30.6) 650 (37.4) .01 0.74 (0.59-0.92)
Day care attendance* 251 (58.8) 906 (53.3) .04 1.25 (1.01-1.55)
Farm environment* 14 (3.2) 105 (6.0) .02 0.51 (0.28-0.87)
Inner-city environment* 147 (33.3) 535 (30.7) .28 1.13 (0.90-1.41)
Pet dog* 165 (37.4) 692 (39.7) .38 0.91 (0.73-1.13)
Pet cat* 163 (37.0) 696 (39.9) .26 0.88 (0.71-1.09)
Serious respiratory tract infection* 46 (11.3) 211 (13.2) .30 0.84 (0.59-1.16)
Adult environment
Smoking 224 (50.8) 928 (53.2) .36 0.91 (0.74-1.12)
Food-related occupation 109 (24.7) 540 (31.0) .01 0.73 (0.57-0.93)
Indigestion medication currently
No or <1/y 386 (87.5) 1513 (86.8) .15 Reference
Yes, <1/mo 35 (7.9) 110 (6.3) 1.25 (0.83-1.84)
Yes, <1/wk 7 (1.6) 30 (1.7) 0.91 (0.37-1.98)
Yes,  1/wk 13 (2.9) 91 (5.2) 0.56 (0.0-0.98)
Comorbid atopy 28 (6.3) 371 (21.3) <.001 3.99 (2.72-6.07)
Pollen sensitization† 340 (80.8) 287 (16.7) <.001 20.96 (16.02-17.70)
IS overallz 37 (8.8) 437 (25.4) <.001 30.47 (21.66-44.10)
Center
Zurich 147 (33.3) 335 (19.2) <.001 4.88 (3.37-7.23)
Madrid 63 (14.3) 246 (14.1) 2.85 (1.86-4.41)
Athens 15 (3.4) 52 (3.0) 3.21 (1.62-6.12)
Utrecht 112 (25.4) 364 (20.9) 3.42 (2.34-5.11)
Lodz 65 (14.7) 313 (17.9) 2.31 (1.52-3.55)
Reykjavik 39 (8.8) 434 (24.9) Reference
Results presented in n (%) unless otherwise specified. Bold indicates statistical significance (P < .05).
*Before the age of 5 y.
†IgE sensitization to birch, grass, mugwort, or parietaria.
zIgE sensitization to pollen, cat, or house-dust mite.
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Prevall project made this possible. In our study, having a pet dog
before the age of 2 years was the only statistically significantly
predictive early-life exposure, and it was found to be strongly
associated with a decreased risk of FS in childhood. Highergestational age at birth was also significantly inversely associated
with childhood FS. No childhood or adult environmental de-
terminants were significantly associated with FS in adulthood,
but demographic characteristics lower age and male sex did make
adult FS more likely.
TABLE III. Independent predictors of FS
Variable
Children Adults
Adjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Demographic characteristic
Age (y) 1.01 (0.91-1.13) .85 0.97 (0.96-0.98) <.001
Male sex 1.01 (0.82-1.25) .92 1.39 (1.12-1.73) <.001
High level of education* 1.02 (0.80-1.29) .88 0.86 (0.67-1.09) .21
Gestational age (wk) 0.93 (0.87-0.99) .01 NA NA
Birth weight (g) 1.00 (1.00-1.00) .97 NA NA
Birth length (cm) 1.01 (0.97-1.06) .65 NA NA
Childhood environment
Maternal age (y) 0.99 (0.97-1.01) .33 1.01 (0.99-1.03) .45
No. of siblings
1 0.86 (0.63-1.18) .28 1.22 (0.75-1.97) .74
2 1.09 (0.73-1.64) 1.34 (0.78-2.29)
3 or more 0.76 (0.40-1.44) 1.35 (0.75-2.42)
No. of older siblings
1 0.85 (0.63-1.15) .62 1.17 (0.85-1.62) .74
2 1.02 (0.63-1.18) 1.21 (0.78-1.88)
3 or more 0.77 (0.31-1.95) 1.22 (0.69-2.14)
Bedroom sharing with other children 0.77 (0.53-1.13)† .18 0.84 (0.62-1.14)z .26
Bedroom sharing with older children 1.19 (0.79-1.80)† .40 0.75 (0.52-1.06)z .11
Day care attendance 0.82 (0.64-1.05)† .12 1.02 (0.80-1.30)z .89
Farm environment 1.06 (0.21-5.36)† .95 0.73 (0.40-1.35)z .32
Inner-city environment 0.94 (0.76-1.17)† .60 1.01 (0.79-1.29)z .93
Pet dog 0.65 (0.48-0.90)† .01 0.94 (0.70-1.27)z .61
Pet cat 1.04 (0.77-1.40)† .79 0.87 (0.68-1.10)z .24
Serious respiratory tract infection 1.11 (0.86-1.45)† .42 0.88 (0.62-1.25)z .47
Use of antibiotics 1.14 (0.89-1.45)† .29 NA NA
Maternal smoking during pregnancy 0.74 (0.51-1.08) .12 NA NA
Maternal smoking since birth 1.12 (0.84-1.48) .45 NA NA
Paternal smoking since birth 0.97 (0.77-1.22) .78 NA NA
Reflux medication in last 6 mo 0.61 (0.17-2.19) .45 NA NA
Infant diet
Vitamin D supplementation 1.05 (0.75-1.47)† .77 NA NA
Breast-feeding duration
4 mo 1.20 (0.82-1.75) .29 NA NA
4-6 mo 1.20 (0.75-1.94) NA NA
>6 mo 0.91 (0.57-1.46) NA NA
Cow’s milk infant formula 0.85 (0.58-1.24) .39 NA NA
Soy milk infant formula 1.35 (0.89-2.05) .16 NA NA
Hypoallergenic infant formula 1.51 (1.06-2.15) .02 NA NA
Age start infant formula
0-4 mo 1.02 (0.60-1.72) .29 NA NA
4-6 mo 1.04 (0.60-1.79) NA NA
6-11 mo 1.10 (0.66-1.82) NA NA
11 mo 1.79 (0.94-3.40) NA NA
Age introduction solid foods
4-6 mo 1.37 (1.00-1.86) .33 NA NA
6-11 mo 1.22 (0.86-1.71) NA NA
11 mo 1.45 (0.93-2.27) NA NA
Adult environment
Smoking NA NA 0.9 (0.79-1.24) .94
Food-related occupation NA NA 0.83 (0.64-1.07) .15
(continued)






Adjusted OR (95% CI) P value Adjusted OR (95% CI) P value
Indigestion medication currently
<1/mo NA NA 1.30 (0.85-1.97) .59
<1/wk NA NA 1.10 (0.46-2.60)
 1/wk NA NA 0.84 (0.46-1.54)
NA, Not available.
Bold indicates statistical significance (P < .05). Analyses were adjusted for center.
Reference categories: “number of (older) siblings” ¼ 0; “indigestion medication” ¼ no or <1/y; “breast-feeding duration” ¼ never; “age start infant formula” ¼ never; “age
introduction solid food ¼ 0-4 mo.
*For children: high level of education of parents.
†Before the age of 2 y.
zBefore the age of 5 y.
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The finding that having a pet dog in early childhood was
inversely associated with FS consolidates existing evidence that
dog ownership protects against childhood FA.19-21 The protec-
tive effect is thought to be the result of exposure to diverse
environmental microbiota.21 Similarly to the adjusted OR of
0.65 (95% CI, 0.48-0.90) in the current study, Koplin et al22
reported an adjusted OR of 0.6 (95% CI, 0.3-0.8) for the as-
sociation between dog ownership and challenge-proven egg,
peanut, and sesame allergy in Australian infants participating in
the HealthNuts study; and Von Hertzen et al11 found an
adjusted OR of 0.57 (95% CI, 0.35-0.95) for the association
between having a dog before the age of 1 year and food and
inhalant sensitization in Finnish schoolchildren aged 7 to 16
years. More recent findings from Europe by Marrs et al21
demonstrate an even stronger relationship, with an adjusted
OR of 0.1 (95% CI, 0.01-0.71) between dog ownership before 3
months and challenge-confirmed FA to cow’s milk, egg white,
cod, peanut, sesame, and wheat in infants aged 1 to 3 years from
the United Kingdom and Wales.21 Perhaps the association is
stronger depending on how young the subject is at exposure, or
depending on how old the subject is when the outcome is
measured. Our finding that having a pet dog in childhood was
not as strongly inversely associated with FS in adulthood as with
FS in childhood, might be explained by the fact that the exposure
to dog before the age of 5 years instead of 2 years was examined
in adults. Or maybe the protective effect does not last until
adulthood. Alternatively, one should consider the fact that the
adults stemmed from an environmentally different childhood era
than the children in this study, which could mean that predictors
for the current adults differ from those for the current children
when reaching adulthood.
Previous literature suggests that environmental factors other
than having a pet dog in childhood also influence the likelihood
of FA.23-26 Two environmental determinants that are relatively
consistently suggested to protect against FA in children are an
increasing number of siblings, especially older siblings,23-26 and
rural or farm lifestyle.23,27,28 In our study, these determinants
also exhibited an inverse association with FS in univariable
analysis, both for children and for adults. However, the suggested
protective effects were attenuated and lost statistical significance
in multivariable analysis. Although the current study was not
specifically powered to detect associations (of minimal relevant
size) for all predictors studied, nor was it designed to assess causal
associations, our study is unique in that it included bothchildhood environmental exposures and infant dietary de-
terminants in multivariable analysis for prediction of childhood
FS, which may influence the observed associations in comparison
with earlier studies where a more limited set of predictive factors
was evaluated. Furthermore, because the outcome FA is often
(partly) defined by a measure of subjective interpretation, sub-
jects self-reporting symptoms may be more likely to report risk
factors associated with FA than subjects without symptoms, thus
possibly inflating associations. Our objective outcome, FS, may
have mitigated these associations.
Nonetheless, several studies also report a significant protective
effect of early-life farm exposure on IgE sensitization, in both
children11,29 and adults.17,30 All these studies, however, focused
on IS. In our study, early-life farm exposure, but also bedroom
sharing in childhood for example, was more strongly inversely
associated with IS than with FS in both children and adults, to
the point of reaching statistical significance. Even larger differ-
ences were observed when comparing IS to primary FS. It is
possible that predictors for FS and IS differ (in effect size),
despite shared pathophysiological mechanisms.
Early-life exposures: Infant diet
Regarding infant diet, none of the dietary determinants eval-
uated in our study significantly predicted FS in childhood, except
for the use of hypoallergenic infant formula. Findings from
models with further adjustment for comorbid atopy and IS,
where the association between the use of hypoallergenic infant
formula and FS lost statistical significance, suggest that reverse
causality may play a role here. In other words, food-sensitized
infants may be more likely to receive hypoallergenic infant for-
mula rather than the other way around.
Literature is inconsistent on whether breast-feeding is pro-
tective against allergy, neutral, or allergy-promoting.31 In
accordance with our findings, most systematic reviews of litera-
ture conclude that there appears to be no significant association
between breast-feeding ever versus never, or breast-feeding
duration, and FA.23,32,33 Interestingly, Hong et al31 found that
breast-feeding significantly increased or decreased the odds of FS
in childhood depending on genotype, implying that individual
genes may decide whether breast-feeding promotes or protects
against FS.31
No significant trend was found for timing of introduction of
infant formula or solid foods and likelihood of FS in childhood
in multivariable analyses, but effect direction did suggest that
earlier introduction of solid foods may protect against FS.
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the least likely FS, as was also concluded in a recent systematic
review and meta-analyses by Burgess et al.34
Demographic characteristics
Demographic factors were taken into account for complete
adjustment, and as expected, some were relevant predictors of FS
in our data. Interestingly, higher gestational age at delivery was
found to be inversely related to FS in childhood. Available
literature on the relationship between gestational age and the
outcome FS is scarce, and previously showed no significant
relationship.35 For the outcome FA, some results are contradic-
tory in that they reveal a positive association between preterm
birth and FA,19,36 whereas others again report no significant
relationship.37,38 Several studies suggest that immune system
homeostasis, gut barrier function, and diversity in gut microbiota
are essential for normal tolerance development.39,40 Because
these features are underdeveloped in preterm infants, this may
make FS more likely. Another possibility is that there is con-
founding through cesarean section, on which we had no data.
Systematic reviews have concluded that cesarean section, which is
more common in preterm births, is positively associated with
both FS and FA, mostly based on the theory that babies born
through cesarean section are deprived of first colonization of the
gut with maternal vaginal bacteria.39,41
In adults, FS significantly decreased with age in our study.
Our data on primary FS in children suggest the same effect di-
rection for children, but the association probably did not reach
statistical significance due to the small age range in included
children (7-10 years). Similar trends were found in cross-
sectional studies in American, Italian, and German children
and adults.42-44 These trends may be the result of increasing
prevalence of FS over time, as suggested by some studies,3,6,7
which would lead to a higher prevalence of sensitization in the
younger age groups.
Male sex was positively associated with FS in adults. The latter
finding appears to contradict the predominating thought that
women are at a higher risk of FA than men.23,26,32,45 However,
with regard to FS, available studies also found that adult males
are more likely to be food sensitized than adult females.42,44
Because many studies investigate the outcome FA rather than
FS, outcome measures are mainly based on patient history.
Because women are more likely than men to report symptoms to
foods,44,46,47 this may explain the discrepancy.
Strengths and limitations
Overall, this study is unique in that data on determinants were
analyzed for the outcomes FS, IS, and primary FS, in both
children and adults, after assessing IgE sensitization to 24 foods.
A limitation is the retrospective data collection on childhood
determinants, which means that some recall bias is likely, espe-
cially in adults. Also, causal inference was limited, because we
had no information on when sensitization developed in relation
to the exposure variables. We did attempt to take the possibility
of reverse causality into account, assessing the change in associ-
ations after adjusting for comorbid atopy. The standardized
approach of this multicenter study all across Europe is a major
strength, allowing valid comparisons. The broad inclusion from
the general population and the use of multiple imputation for
sporadically missing data on determinants yielded a large studypopulation in which we could evaluate most currently conceived
environmental, infant dietary, and demographic risk factors.
CONCLUSIONS
Our findings consolidate existing evidence that dog ownership
in early childhood protects against FS in later childhood. Other
postulated environmental and infant dietary risk factors for FA
appear to have (more) limited impact on childhood or adult FS
after mutual adjustment, though preventative tendencies were
observed for certain early-life exposures, including early intro-
duction of solid foods. Demographic factors also appear relevant,
in that gestational age affects the likelihood of childhood FS, and
age and sex the likelihood of adult FS.
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METHODS
Questionnaires
The EuroPrevall phase I screening questionnaire was a self-
administered 1-page document, designed to detect subjects
with and without food-related reactions. The phase II ques-
tionnaire was an extensive interviewer-administered question-
naire on symptoms and potential risk factors for FA (Figures E2
and E3).
Determinants
Data on evaluated childhood environmental determinants
were obtained from the phase II questionnaire, and consisted of
maternal age at the birth of subject, number of siblings, number
of older siblings, bedroom sharing with any sibling and with
older siblings, day care attendance, dog or cat ownership,
growing up on a farm, growing up in the inner-city, and having
serious respiratory infections. In children, antibiotic use before
the age of 2 years, use of reflux medication in the previous 6
months, maternal smoking during pregnancy, and maternal and
paternal smoking since the birth of the subject (at least 1 ciga-
r(ette) per day) were also investigated. Regarding infant diet,
duration of breast-feeding, age of start of infant formula, type of
infant formula (cow’s milk, soy milk, hypoallergenic), age of
introduction of solid foods, and vitamin D supplementation
before the age of 2 years were assessed. For adults, environmental
determinants later in life were food-related occupation (everworked in the growing, production, processing, or distribution of
food), smoking (ever for longer than 1 year), and frequency of
use of indigestion medication (antacids, H2-antagonists, or
proton pump inhibitors).
Demographic factors, consisting of age, sex, and (parental)
level of education for all subjects, and gestational age at birth,
birth length, and weight for children, were also evaluated.
Food and inhalant allergens
Specific IgE testing was performed in phase II for 24 foods,
which are often implicated in FA or frequently consumed across
Europe. These foods were hen’s egg, cow’s milk, fish, shrimp,
peanut, hazelnut, walnut, peach, apple, kiwi, melon, banana,
tomato, celery, carrot, corn, lentils, soy, wheat, buckwheat, ses-
ame seed, mustard seed, sunflower seed, and poppy seed. They
were termed priority foods. IgE testing was also performed for 6
common inhalant allergens: birch, mugwort, grass, and parietaria
pollen, house-dust mite, and cat.
IgE testing
All serum samples were analyzed in a single laboratory in the
Academic Medical Center, Amsterdam, The Netherlands, using
commercially available ImmunoCAP tests (Phadia, currently
ThermoFisher Scientific, Uppsala, Sweden). All sera that tested
positive for at least 1 of the priority foods in phase II, and a
random sample of nonsensitized controls, were further tested for
specific food allergens using an allergen microarray assay.E1-E3
FIGURE E1. Classification of FS into primary sensitization and cross-reactive sensitization. Subjects were classified into 1 or more of the
boxes depending on their sensitization patterns (ie, subjects could have both primary and cross-reactive sensitization). This is a simplified
classification, designed for exploratory purposes, and subjects with cross-reactive sensitization through food rather than pollen, or with
cross-reactive sensitization to tropomyosins (eg, shrimp through house-dust mite), have been classified as primary sensitization. How-
ever, aforementioned cross-reactivity patterns are much less common than pollen-related cross-reactivity, and are expected to have only
limited influence on the prevalence of primary FS. In the prediction modeling of the outcome primary sensitization, the negative outcome
comprised no sensitization, or cross-reactive sensitization only. CCD, cross-reactive carbohydrate determinants; PR-10, pathogenesis-















FIGURE E2. Relationship between FS, primary FS, and IS in (A) children and (B) adults. The numbers (%) represent individual subjects
included in the study with the particular (combination of) outcome(s). Only subjects with complete data on FS, primary FS, and IS were
included in these diagrams.
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DAY     MONTH   YEAR
Today’s da
DAY     MONTH   YEAR
1. What is this child’s date of birth?
male female
2. Sex of child
FOOD ALLERGY
3. Has this child ever had an illness or problem caused by eating any of the following foods? Say 
whether or not this child avoids them because they make him/her ill, and approximately how often this
child eats the following foods:
*     Other cow’s milk products including butter, cheese, yoghurt, crème fraiche, fromage frais….
**    Including wheat products such as bread and breakfast cereals
FOOD Has this child ever 
had an illness or problem
caused by eating any of 
the follow ing foods?







How  often does this child eats this food
(in season)
Tick one column only








































FIGURE E3. EuroPrevall phase II questionnaire for children.
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NO         YES
4. Has this child had any problems eating any other food or foods? 
If yes please list the foods:
CODE
4.1 Food  ______________________________________________________
CODE
4.2 Food  ______________________________________________________
CODE
4.3 Food  ______________________________________________________
If you have answered ‘NO’ to questions 3 AND 4 please go to question 5.  
If ‘YES’:
CODE
4.4 Which of all these foods mentioned above gave this child the worst 
problems? _____________________
YEARS
4.5 How old was this child when he/she had his/her first problem eating this food?
4.6 How old was this child when he/she had his/her most recent problem eating YEARS
this food?





More than 4 times
NO YES
4.8 Has this child avoided eating this food since his/her illness or problem?
4.9 Did this illness or problem include:
NO YES
4.9.1 Itching, tingling or swelling in the mouth, lips or throat?
4.9.2 A rash, nettle sting like rash or itchy skin?
4.9.3 Diarrhoea or vomiting (other than food poisoning)?
4.9.4 Runny or stuffy nose?
4.9.5 Red, sore or running eyes?
4.9.6 Difficulty swallowing?
4.9.7 Breathlessness?
4.9.8 Stiffness in his/her joints?
4.9.9 Fainting or dizziness?
4.9.10 Headaches?
NO YES
4.10 Has this child had any other symptoms when eating this food?
If yes, please describe ________________________________________________
4.11 How long after eating the food did this
child start with the first symptom?
Minutes: Hours: Days:
FIGURE E3. Continued
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4.12 How long did it last? Minutes: Hours: Days:
NO          YES
4.13 Did this child receive any treatment?
If yes, could you tell us the name of any medicine used
CODE
4.13.1 Medicine  ______________________________________________________
CODE
4.13.2 Medicine  ______________________________________________________
CODE
4.13.3 Medicine  _______________________________________________ _______
NO YES
5. Have you ever been told by a doctor that this child has a food allergy?
DON’T 
NO YES    KNOW
6. Has this child received vitamin D as a supplement in the first two years of
life?
7. Does this child drink milk?
please tick
one only
8. Does this child eat butter or margarine?
please tick
one only
Yes, mostly butter 
Yes, mostly margarine 
No
ASTHMA AND ALLERGIES
9. Has this child had wheezing or whistling in his/her chest at any time in the last NO YES
12 months?
If ‘NO’ go to question 10.
If ‘YES’:
NO YES
9.1 Has this child been at all breathless when the wheezing noise was present?
NO YES
9.2. Has this child had this wheezing or whistling when he/she did not have a cold?
NO YES
10. Has this child ever had asthma?
If ‘NO’ go to question 11.
Yes, mostly full fat milk 
Yes, mostly half fat milk 
Yes, mostly low fat milk
No
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10.1 How old was this child when he/she had his/her first attack of asthma?
NO YES
10.2 Has this child had an attack of asthma in the last 12 months?
If ‘NO’ go to question 11.
If ‘YES’: 
10.3 How many times has this child been woken up because of his/her asthma in the last 12 months?
please tick
one only
Every night or almost every night
More than once a week, but not most nights
At least twice a month, but not more than once a week
Less than twice a month
Not at all
NO   YES
11. Does this child have any nasal allergies, including hay fever?
If ‘NO’ go to question 11.2.
If ‘YES’:  
YEARS
11.1 How old was this child when he/she first had hay fever or nasal allergy?
11.2. Has this child ever had a problem with sneezing, or a runny or a blocked NO YES
nose when he/she did not have a cold or the flu?
If ‘NO’ go to question 11.4, if ‘YES’:  
11.3. Has this child had a problem with sneezing or a runny or blocked NO   YES
nose when he/she did not have a cold or the flu in the last 12 months?
If ‘NO’ go to question 12.
If ‘YES’:  
NO   YES
11.4 Has this nose problem been accompanied by itchy or watery eyes?
12. Has this child ever had an itchy rash that was coming and going for at NO YES
least 6 months?
If ‘NO’ go to question 12.2.
If ‘YES’:  
YEARS
12.1 How old was this child when he/she first had this itchy rash?
12.2 Has this child had an itchy rash at any time that affected any of the following places:
NO YES
12.2.1 the folds of the elbows
12.2.2 behind the knees
12.2.3 in front of the ankles
12.2.4 around the neck
12.2.5 around the ears
12.2.6 around the eyes
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If ‘YES’ to any of the above:
NO    YES
12.3 Has this child had this itchy rash at any time in the last 12 months?
NO    YES
13. Has this child ever had eczema?
14. When this child is near animals, such as cat as a dog or a horse, does he/she ever
NO YES
14.1 start to cough?
14.2 start to wheeze?
14.3 get a feeling of tightness in his/her chest?
14.4 start to feel short of breath?
14.5 get a runny or stuffy nose or start to sneeze?
14.6 get itchy or watering eyes?
15. When this child is near trees, grass or flowers, or when there is a lot of pollen about, 
does he/she ever
NO YES
15.1 start to cough?
15.2 start to wheeze?
15.3 get a feeling of tightness in his/her chest?
15.4 start to feel short of breath?
15.5 get a runny or stuffy nose or start to sneeze?
15.6 get itchy or watering eyes?
DON’T
NO  YES KNOW
16. Has this child ever had immunotherapy for allergy?
If ‘NO’ or ‘DON’T KNOW’ go to question 17.
If ‘YES’:






16.1.5 I don’t know
17. Within the last 6 months:
17.1 Has this child vomited when NOT having “winter vomiting disease” or food NO  YES   
poisoning?
17.2 Has this child complained of feelings like vomiting or feeling nauseous NO    YES 
when NOT having “winter vomiting disease” or food poisoning?
17.3 Has this child complained of having a burning or painful feeling in the NO    YES 
middle of his/her chest?
17.4 Has this child, complained of having a sour taste, like the taste of NO    YES 
vomit in his/her mouth?
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17.5. Within the last 6 months, has this child taken any medications for acid NO    YES
regurgitation /gastroesophageal reflux?   
If yes, which medicine was/is it? (including antacids over-the-counter) : 
CODE
17.5.1 Medicine  ______________________________________________________
CODE
17.5.2 Medicine  ______________________________________________________
CODE
17.5.3 Medicine  ______________________________________________________
PREGNANCY AND BIRTH OF THIS CHILD
YEARS
18. How old was the mother when she gave birth to this child?
WEEKS
19. At how many weeks of pregnancy was this child born?
CENTIMETERS
20. What was the length of this child when it was born?
GRAM
21. What was the weight of this child when it was born?







23. What country was this child born in? _______________________________
IF NOT THIS COUNTRY: YEARS
23.1 How old was this child when he/she left the country of his/her birth?
NO    YES
24. Did the mother have an alcoholic drink during her pregnancy of this child?




Once every couple of months
Once or twice a month
Once or twice a week
Three or four days a week
Almost every day
NO    YES
25. Did the mother smoke during her pregnancy of this child?
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If yes, on average during the time of the pregnancy of this child, how much did the mother 
smoke? 
25.1 number of cigarettes per day
25.2 other tobacco in grams / week
INFANT FEEDING
NO YES
26. Was this child ever breastfed?
Breastfeeding also means expressed breast milk given in a bottle
If ‘NO’ go to question 27.
If ‘YES’:
26.1 How old was this child when the 
breastfeeding was stopped completely?
Days: Weeks: Months:
NO YES
27. Has this child ever received any infant formula?
If ‘NO’ go to question 28.
If ‘YES’:
27.1 How old was this child when he/she
received the formula for the first time?
Days: Weeks: Months:
27.2 How old was this child when feeding 
the formula was stopped?
Days: Weeks: Months:
27.3 Which of the following types of infant formula has this child received?
please tick
WEEKS
28. At what age were supplemental liquids other than milk and water started?
WEEKS
29. At what age were solid foods started?
OTHER ISSUES RELATED TO HEALTH AND DISEASE
30. Did this child have a serious respiratory infection before the age NO YES   
of two years?
NO YES
31. Was this child hospitalised before the age of two years for lung disease?
NO YES
32. Was this child ever given antibiotics in the first two years of life?
27.3.1 Normal cow’s milk formula
27.3.2 Normal soy milk formula
27.3.3 Hypo-allergenic (modified) formula
27.3.4 Other (please specify)……………………………………………………………………
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YOU AND YOUR HOUSEHOLD
NUMBER    
33. How many brothers and sisters does this child have or did have?
If ‘NONE’ go to question 34.
If ‘YES’:
NUMBER   
33.1 How many older brothers and sisters?
33.2 How many younger brothers and sisters?
33.3 How many of the brothers and sisters ever had asthma?
33.4 How many of the brothers and sisters, who did not have asthma, ever had
other allergies such as eczema or skin allergies, nasal allergy or hay fever?
34. How many other children regularly slept in this child’s bedroom before CHILDREN
he/she was two years old? 
35. Did this child regularly share his/her bedroom with any older children NO YES  
before the age of two years?
36. Did this child go to a school, play-school or nursery with older NO YES   
children before the age of two years?
If ‘NO’ go to question 37.
If ‘YES’:
MONTHS
36.1 At what age did this child first attend a school, play school, day care or nursery?
37. What term best describes the place this child lived most of the time




Village in a rural area
Small town
Suburb of a city
Inner city
Combination of rural and town/city* 
*for example when staying regularly with family at the country site during weekends







38.5 Guinea pigs or other furry animals
38.6 Other: ____________________________________________________
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39.5 Guinea pigs or other furry animals
39.6 Other: ____________________________________________________









41. What country was the mother born in? _______________________________
DON'T
NO YES   KNOW
42. Did the mother ever have a food allergy?
DON'T
NO YES   KNOW
43. Did the mother ever have asthma?
DON'T
NO YES   KNOW
44. Did the mother ever have eczema or skin allergy?
DON'T
NO YES   KNOW
45. Did the mother ever have nasal allergy or hay fever?
46. What level of education had the mother completed? NO      YES      
46.1 Has she completed primary education?
46.2 Has she completed her secondary education?                      
46.3 Has she been awarded a lower level vocational education diploma?
46.4 Has she been awarded a higher level vocational education diploma?
46.5 Has she been awarded a university degree?
NO YES   
47. Is the mother currently employed (or self-employed)?
If ‘NO’ or ‘DON’T KNOW’ go to question 48.
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48. Has the mother ever worked in a job relating to the growing, production, NO YES   KNOW
processing or distribution of food?
If ‘NO’ or ‘DON’T KNOW’ go to question 49.
If ‘YES’:




NO YES   KNOW
49. Has the mother ever worked in a job in which she used latex gloves?
If ‘NO’ or ‘DON’T KNOW’ go to question 50.
If ‘YES’:
DON'T
NO YES   KNOW
49.1. Were these ever powdered latex gloves?
NO YES   
50. Has the mother smoked since the birth of this child?
'YES' means at least one cigarette per day or one cigar or 360g of tobacco a week
If ‘NO’ go to question 51.
If ‘YES’:
NO YES   
50.1 Was the mother smoking when the child was born?
If ‘NO’ go to question 50.3.
If ‘YES’:
50.2. On average when the child was born of this child, how much did the mother smoke? 
50.2.1 number of cigarettes per day
50.2.2 other tobacco in grams / week
Go to question 50.5
YEARS 
50.3 How old was this child when the mother started smoking (again)?
50.4. On average at the time the mother started smoking (again), how much did the mother 
smoke? 
50.4.1 number of cigarettes per day
50.4.2 other tobacco in grams / week
50.5 On average how much does the mother now smoke?
50.5.1 number of cigarettes per day
50.5.2 other tobacco in grams / week
50.5.3 stopped smoking
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If the mother stopped smoking:
YEARS 
50.6 How old was this child when the mother stopped smoking?
51. How many people in your household smoked regularly in the house NUMBER
in the first 2 years of life of this child?
‘Regularly’ means on most days
52. How many hours a day was this child exposed to tobacco smoking HOURS 
in the first 2 years of life?
NUMBER
53. How many people in your household smoke regularly in the house now?
‘Regularly’ means on most days
HOURS 
54. How many hours a day is this child exposed to tobacco smoking?
ABOUT THE FATHER
CODE
55. What country was the father born in? _______________________________
DON’T
NO YES   KNOW
56. Did the father ever have a food allergy?
DON'T
NO YES   KNOW
57. Did the father ever have asthma?
DON'T
NO YES   KNOW
58. Did the father ever have eczema or skin allergy?
DON'T
NO YES   KNOW
59. Did the father ever have nasal allergy or hay fever?
60. What level of education had the father completed?
NO      YES      
60.1 Has he completed primary education?
60.2 Has he completed his secondary education?                      
60.3 Has he been awarded a lower level vocational education diploma?
60.4 Has he been awarded a higher level vocational education diploma?
60.5 Has he been awarded a university degree?
NO YES   
61. Is the father currently employed (or self-employed)?
If ‘NO’ go to question 62
If ‘YES’:








62. Has the father ever worked in a job relating to the growing, production,    NO YES   KNOW
processing or distribution of food?
If ‘NO’ or ‘DON’T KNOW’ go to question 63.
If ‘YES’:




NO YES   KNOW
63. Has the father ever worked in a job in which he used latex gloves?
If ‘NO’ or ‘DON’T KNOW’ go to question 64.
If ‘YES’:
DON'T
NO YES   KNOW
63.1. Were these ever powdered latex gloves?
NO YES   
64. Has the father smoked since the child was born?
['YES' means at least one cigarette per day or one cigar or 360g of tobacco a week]
If ‘NO’ go to question 65, if ‘YES’:
NO YES   
64.1 Was the father smoking when the child was born?
If ‘NO’ go to question 64.3, if ‘YES’:
64.2. On average when the child was born, how much did the father smoke? 
64.2.1 number of cigarettes per day
64.2.2 other tobacco in grams / week
Go to question 64.5
YEARS 
64.3 How old was this child when the father started smoking (again)?
64.4. On average at the time the father started smoking (again), how much did he smoke? 
64.4.1 number of cigarettes per day
64.4.2 other tobacco in grams / week
64.5 On average how much does the father smoke now?
64.5.1 number of cigarettes per day
64.5.2 other tobacco in grams / week
64.5.3 stopped smoking
If the father stopped smoking:
YEARS 
64.6 How old was this child when the father stopped smoking?
NO YES
65. Are you willing to be contacted again for further food allergy studies?
Thank you very much for completing this questionnaire
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DAY     MONTH   YEAR
Date
DAY     MONTH   YEAR
1. What is your date of birth?
MALE  FEMALE
2. Are you male or female?
3. Have you ever had an illness or trouble caused by eating any of the following foods?
Tick as 
many as                     
apply
3.1     Cow’s milk*
3.2.    Hen’s eggs
3.3.    Fish
3.4.    Shrimp or Lobster
3.5.    Other shellfish
3.6.    Peanut
3.7.    Hazelnut
3.8.    Walnut
3.9.    Chocolate
3.10.  Peach
3.11.  Apple
















3.28.  Sesame seed
3.29.  Mustard seed
3.30 Sunflower seed
3.31.  Poppy seed
* Other cow’s milk products including butter, cheese, yoghurt, crème fraiche, fromage frais….
**    Including wheat products such as bread and breakfast cereals
FIGURE E4. EuroPrevall phase II questionnaire for adults.
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4. Have you had any problems eating any other food or foods?   If yes please list the 
foods:
CODE
4.1 Food  ______________________________________________________
CODE
4.2 Food  ______________________________________________________
CODE
4.3 Food  ______________________________________________________
If you have answered ‘NO’ to questions 3 AND 4 please go to question 5.  
If ‘YES’:
CODE
4.4 Which of all these foods gave you the worst problems?  _____________________
YEARS
4.5 How old were you when you had your first problem eating this food?
4.6 How old were you when you had your most recent problem eating YEARS
this food?
4.7 How often have you had this illness or trouble after eating this food? please tick
Only once
2-4 times
More than 4 times
NO YES
4.8.      Have you avoided eating this food since your illness or trouble?
4.9 Did this illness or trouble include:            
NO YES
4.9.1. Itching, tingling or swelling in the mouth, lips or throat?
4.9.2. A rash, nettle sting like rash or itchy skin?
4.9.3. Diarrhoea or vomiting (other than food poisoning)?
4.9.4. Runny or stuffy nose?
4.9.5. Red, sore or running eyes?
4.9.6. Difficulty swallowing?
4.9.7. Breathlessness?
4.9.8. Stiffness in your joints?
4.9.9. Fainting or dizziness?
4.9.10. Headaches?
NO YES
4.10.   Have you had any other symptoms?
If yes, please describe  ________________________________________________
4.11. How long after eating the food did 
you start with the first symptom?
Minutes: Hours: Days:
4.12. How long did it last? Minutes: Hours: Days:
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4.13. Did you receive any treatment? NO YES
If yes, could you tell us the name of any medicine used
CODE
4.13.1 Medicine  ______________________________________________________
CODE
4.13.2 Medicine  _____________________________________ _________________
CODE
4.13.3 Medicine  ______________________________________________________
NO YES
4.14.         Have you ever been told by a doctor that you have a food allergy?
5. Say approximately how often you eat the following foods, and whether or not you 
avoid them because they make you ill:
* Other cow’s milk products including butter, cheese, yoghurt, crème fraiche, fromage frais….
**    Including wheat products such as bread and breakfast cereals
FOOD Do you avoid this
food because it 
makes you ill?
How often do you eat this food
(in season)














































6. Have you had wheezing or whistling in your chest at any time in the last NO YES
12 months?
IF 'NO' GO TO QUESTION 7, IF 'YES': 
NO YES
6.1 Have you been at all breathless when the wheezing noise was present?
6.2. Have you had this wheezing or whistling when you did not have NO YES
a cold?
NO YES
7. Have you ever had asthma?
IF 'NO' GO TO QUESTION 8, IF 'YES':
NO YES
7.1 Was this confirmed by a doctor?
YEARS
7.2 How old were you when you had your first attack of asthma?
YEARS
7.3 How old were you when you had your most recent attack of asthma?
7.4. Which months of the year do you usually have attacks of asthma?
NO YES
7.4.1 January / February
7.4.2 March / April
7.4.3 May / June
7.4.4 July / August
7.4.5 September / October
7.4.6 November / December
NO YES
7.5 Have you ever been admitted to hospital with an attack of asthma?
NO YES
7.6 Have you had an attack of asthma in the last 12 months?
IF NO GO TO Q8, IF YES ATTACKS
7.6.1 How many attacks of asthma have you had in the last 12 months?
ATTACKS
7.6.2 How many attacks of asthma have you had in the last 3 months?
7.7 How many times have you been woken up because of your asthma in the last 3 months?
TICK ONE BOX ONLY
Every night or almost every night 1
More than once a week, but not most nights 2
At least twice a month, but not more than once a week 3
Less than twice a month 4
Not at all 5
7.8 How often have you had trouble with your breathing because of your asthma in the last 3 
months?
TICK ONE BOX ONLY
Continuously 1
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About once a day 2
At least once a week, but less than once a day 3
Less than once a week 4
Not at all 5
NO   YES
8. Do you have any nasal allergies, including hay fever?
IF NO GO TO Q9, IF YES YEARS
8.1 How old were you when you first had hay fever or nasal allergy?
9. Have you ever had a problem with sneezing, or a runny or a blocked NO YES
nose when you did not have a cold or the flu?
IF NO GO TO Q10, IF YES
9.1.Have you had a problem with sneezing or a runny or blocked NO   YES
nose when you did not have a cold or the flu in the last 12 months?
IF NO GO TO Q10, IF YES
9.1.1. Has this nose problem been accompanied by itchy or  NO   YES
watery eyes?
9.1.2. In which months of the year did this nose problem occur? NO YES
9.1.2.1  January/ February
9.1.2.2  March/ April
9.1.2.3  May/ June
9.1.2.4  July/ August
9.1.2.5  September/ October
9.1.2.6  November/ December
10. Have you ever had an itchy rash that was coming and going for at NO YES
least 6 months?
IF NO GO TO Q11, IF YES YEARS
10.1 How old were you when you first had this itchy rash?
NO YES
10.2. Have you had this itchy rash in the last 12 months?
11. Have you had an itchy rash at any time that affected any of the following places:
NO YES
11.1.1 the folds of the elbows
11.1.2 behind the knees
11.1.3 in front of the ankles
11.1.4 around the neck
11.1.5 around the ears
11.1.6 around the eyes
IF 'YES' TO ANY OF THE ABOVE:
NO    YES
11.2 Have you had this itchy rash in the last 12 months?
12. When you are near animals, such as cats, dogs or horses, do you ever
NO YES
12.1 start to cough?
12.2 start to wheeze?
12.3 get a feeling of tightness in your chest?
12.4 start to feel short of breath?
12.5 get a runny or stuffy nose or start to sneeze?
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12.6 get itchy or watering eyes?
13. When you are near trees, grass or flowers, or when there is a lot of pollen
about, do you ever
NO YES
13.1 start to cough?
13.2 start to wheeze?
13.3 get a feeling of tightness in your chest?
13.4 start to feel short of breath?
13.5 get a runny or stuffy nose or start to sneeze?
13.6 get itchy or watering eyes?
IF 'YES' TO ANY OF THE ABOVE:





14. After taking any medicines (including antibiotics) have you ever had any of the 
following 
NO          YES
14.1.1 Itching, tingling or swelling in the mouth, lips or throat?
14.1.2 A rash, nettle sting like rash or itchy skin?
14.1.3 Diarrhoea or vomiting ?
14.1.4 Runny or stuffy nose?
14.1.5 Red, sore or running eyes?
14.1.6 Difficulty swallowing?
14.1.7 Breathlessness?
14.1.8 Stiffness in your joints?
14.1.9 Fainting or dizziness?
14.1.10 Headaches?
NO YES
14.2 Have you had any other symptoms after taking medicines?
14.2.1 If yes, please describe  ________________________________________________







NO  YES DON’T KNOW
15. Have you ever had immunotherapy for allergy?
IF 'NO' OR 'DON'T KNOW' GO TO QUESTION 16, IF 'YES':
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15.2 How old were you when you first had immunotherapy?
YEARS
15.3 How old were you when you last had immunotherapy?
15.4 Was the immunotherapy NO YES
a) By injection?
b) Under your tongue?
c) Other?
INDIGESTION
16. How often do you get any of the following symptoms?  
<1/      <1/      <1/      1-2/     3-5/    every
Never    year   month   week  week    week   day
16.1    Regurgitating stomach contents
16.2    Burning sensation behind the breastbone
16.3    Acid taste in the mouth
16.4    Have you woken with any of these symptoms?
<1/      <1/      <1/      1-2/     3-5/    every
Never    year   month   week  week    week   day
16.5  How often do you take medicine bought
without prescription for indigestion?  
16.6  How often do you take medicine 
prescribed by your doctor for indigestion?  
IF 'NEVER' GO TO QUESTION 17,  otherwise
16.7 Which medicine was/is this?
CODE
16.7.1 Medicine  ______________________________________________________
CODE
16.7.2 Medicine  ______________________________________________________
CODE
16.7.3 Medicine  ____________________________________________________ __
16.8 How old were you when you first started taking any regular treatment for YEARS
indigestion?
16.9 Have you taken any medicine prescribed by your doctor for indigestion NO     YES
in the last 3 months?
NO     YES
16.10 Have you ever had an operation to cure or help your indigestion?
SMOKING
NO YES
17. Have you ever smoked for as long as a year?
['YES' means at least one cigarette per day or one cigar a week for one year or 360g of tobacco]
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IF 'NO' GO TO QUESTION 18, IF 'YES':
YEARS
17.1 How old were you when you started smoking?
NO YES
17.2 Do you now smoke, as of one month ago?
IF 'NO' GO TO QUESTION 17.3, IF 'YES': 
How much do you now smoke on average? NUMBER  
17.2.1 number of cigarettes per day
17.2.2 number of cigarillos per day
17.2.3 number of cigars a week
17.2.4 pipe tobacco in grams / week
NO YES
17.3 Have you stopped or cut down smoking?
IF 'NO' GO TO QUESTION 17.4 IF 'YES': YEARS
17.3.1 how old were you when you stopped or cut down smoking?
17.3.2 on average of the entire time you smoked, before you stopped
or cut down, how much did you smoke? NUMBER  
17.3.2.1 number of cigarettes per day
17.3.2.2 number of cigarillos per day
17.3.2.3 number of cigars a week
17.3.2.4 pipe tobacco in grams / week
NO YES
17.4 Do you or did you inhale the smoke?
ALCOHOL
18. Please read the following statements carefully and tick the box next to the one t hat best 
describes you:
TICK ONE ONLY
18.1.1  I have never tasted an alcoholic drink
18.1.2    I have tasted alcohol once or twice, but never had a whole drink
18.1.3    I have had a proper alcoholic drink – a whole drink not just a taste
YEARS
18.2  How old were you the first time you had a proper alcoholic drink?
18.3  How often do you usually have an alcoholic drink:
TICK ONE ONLY
Less than once a year
Once or twice a year
Once every couple of months
Once or twice a month
Once or twice a week
Three or four days a week
Five or six days a week
Almost every day
18.4 How much of the following have you drunk in the last seven days:
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18.4.1  Draught Beer, Lager or Cider Litres/Pints
18.4.2  Beer, Lager or Cider 330ml cans/bottles
18.4.3  Beer, Lager or Cider 660ml cans/bottles
18.4.4  Measures of spirits (doubles count as 2) e.g. gin, vodka, whisky ,  rum measures
18.4.5  Fortified wine (e.g. sherry, martini, port, vermouth, cinzano, dubonnet) measures
18.4.6  Wine (125ml glasses) 125 ml glasses




19.1 How many brothers and sisters do or did you have?
IF 'NONE' GO TO QUESTION 20.1, IF 'YES': 
DON'T
NUMBER   KNOW
19.2.1 How many older brothers and sisters?
19.2.2 How many younger brothers and sisters?
19.2.3 How many of your brothers and sisters ever had asthma?
19.2.4 How many of your brothers and sisters, who did not have asthma, ever had
other allergies such as eczema or skin allergies, nasal allergy or hay fever?
DON'T
NO YES   KNOW
19.3 Did your mother ever have asthma?
DON'T
NO YES   KNOW
19.4 Did your mother ever have eczema, skin or nasal allergy or hay fever?
DON'T
NO YES   KNOW
19.5 Did your father ever have asthma?
DON'T
NO YES   KNOW
19.6 Did your father ever have eczema, skin or nasal allergy or hay fever?
EDUCATION AND WORK
NO YES
20.1 Are you a full time student?
IF 'YES' GO TO QUESTION 20.3, IF 'NO': 
YEARS
20.2 At what age did you complete full time education?
20.3 What level of education have you completed?
NO       YES
FIGURE E4. Continued
J ALLERGY CLIN IMMUNOL PRACT
OCTOBER 2020
3083.e23 LYONS ETAL
20.3.1 Have you completed primary education?
20.3.2 Have you completed your secondary education?
20.3.3 Have you been awarded a lower level vocational education diploma?
20.3.4 Have you been awarded a higher level vocational education diploma?
20.3.5  Have you been awarded a university degree
NO YES
20.4 Are you currently employed (or self-employed)?
IF 'YES' GO TO QUESTION 20.5, IF 'NO': 
NO YES
20.4.1 Are you currently looking for a job?
20.5 What is your current or most recent job? [Be as precise as possible]
CODE
_________________________________________________
20.6 Are you or were you TICK ONE
BOX ONLY
a) a manager working for an employer? 1
b) a foreman or supervisor working for an employer? 2
c) working for an employer, but neither a manager, supervisor or foreman? 3
d) self-employed? 4
21. Have you ever worked in a job relating to the growing, production,   NO YES
processing or distribution of food?
IF 'NO' GO TO QUESTION 21.2 IF 'YES': YEARS
21.1 How old were you when you first did this type of job?
21.1.1 What was or is this job? [Be as precise as possible]
CODE
________________________________________________
21.1.2 Does/did this involve NO YES




21.1.3 What foods were involved?     _______________________________
_______________________________
_______________________________
21.2 To what extent are you involved with food preparation at home? TICK ONE
BOX ONLY
a) Have noting to do with food preparation 1
b) Sometimes present in the kitchen when food is being prepared 2
c) Occasionally prepare and cook food in the kitchen 3
d) Prepare and cook food in the kitchen at least once a week 4
e) Prepare and cook food in the kitchen on most days 5
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NO YES
21.3 Have you ever worked in a job in which you used latex gloves?
IF NO, go to question 22; IF YES YEARS
21.12 How old were you when you first did this type of job?
NO YES
21.12.1 Were these ever powdered latex gloves?
22. YOUR CHILDHOOD
YEARS
22.1 How old was your mother when you were born?
CODE
22.2 What country were you born in? _______________________________
IF NOT THIS COUNTRY: YEARS
22.2.1 How old were you when you left the country of your birth?
22.3. How many times did you move house during the first five
years of your life? TICK ONE BOX ONLY
None 1
Once 2
more than once 3
22.4 What term best describes the place you lived most of the time
when you were under the age of five years? TICK ONE BOX ONLY
a)  farm 1
b)  village in a rural area 2
c)  small town 3
d)  suburb of a city 4
e)  inner city 5







22.5.5 guinea pigs or other furry animals
22.5.6 other: ____________________________________________________
22.6  How many other children regularly slept in your bedroom before CHILDREN
you were five years old? 
DON’T
22.7 Did you regularly share your bedroom with any older children NO YES  KNOW 
before the age of five years?
DON’T
22.8 Did you go to a school, play-school or nursery with older children NO YES   KNOW
before the age of five years?
YEARS 
22.9  At what age did you first attend a school, play school, day care or nursery?
DON’T
22.10  Did you have a serious respiratory infection before the age of five NO YES   KNOW
years?
NO YES
22.11 Were you hospitalised before the age of two years for lung disease?
NO YES
23. Are you willing to be contacted again for further food allergy s tudies?
Thank you very much for completing this questionnaire
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TABLE E1. Amount of missing data in predictor variables




Level of education 0 0
Gestational age 26 NA
Birth weight 31 NA
Birth length 76 NA
Childhood environment
Maternal age 7 5
No. of siblings 6 9
No. of older siblings 6 9
Bedroom sharing with any sibling 6 2
Bedroom sharing with older children 2 11
Day care attendance 2 58
Farm environment 0 0
Inner-city environment 0 0
Pet dog 1 0
Pet cat 1 0
Serious respiratory tract infection 1 186
Use of antibiotics 2 NA
Maternal smoking during pregnancy 3 NA
Maternal smoking since birth 2 NA
Paternal smoking since birth 2 NA
Reflux medication in last 6 mo 0 NA
Infant diet
Vitamin D supplementation 123 NA
Breast-feeding duration 30 NA
Cow’s milk infant formula 22 NA
Soy milk infant formula 26 NA
Hypoallergenic infant formula 25 NA
Age start infant formula 31 NA
Age introduction solid foods 50 NA
Adult environment
Smoking NA 0
Food-related work NA 0
Indigestion medication NA 0
Variables for model adjustment
Comorbid atopy 50 103
Parental FA 233 NA
Sensitization to pollen 32 44
Sensitization to HDM or cat 32 44
Primary FS 1 0
Center 0 0
HDM, House-dust mite; NA, not available.
Values for these missing data were estimated using multiple imputation procedures, for which all the above determinants were included as covariates, along with the outcome
FS.
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(N [ 71) P
Age (y), mean  SD 8.9  1.0 8.9  0.9 .937 38.3  9.6 38.1  9.0 .842
Sex
Male 1096 (49.9) 61 (46.9) .508 932 (42.7) 20 (28.2) .015
Female 1100 (50.1) 69 (53.1) 1253 (57.3) 51 (71.8)
Highest level of education (parents)
High 938 (42.7) 61 (46.9) .348 1436 (65.7) 44 (62.0) .513
Low 1257 (57.3) 61 (46.9) 749 (34.3) 27 (38.0)
Allergic asthma 416 (18.9) 22 (16.9) .567 323 (14.8) 6 (8.5) .137
Allergic rhinitis 710 (32.3) 43 (33.1) .860 1093 (50.0) 34 (47.9) .810
Atopic dermatitis 833 (37.9) 56 (43.1) .241 393 (18.0) 10 (14.1) .398
Family atopy 1732 (81.9) 102 (81.6) .935 1411 (73.7) 36 (63.2) .075
Parental FA 505 (25.7) 31 (27.0) .769 NA NA NA
Symptoms to any foods 917 (41.8) 53 (40.8) .824 1121 (51.3) 31 (43.7) .205
Symptoms to priority foods 661 (30.1) 30 (23.1) .089 744 (34.1) 18 (25.4) .127
Center
Zurich 304 (13.8) 26 (20.0) <.001 482 (22.1) 22 (31.0) <.001
Madrid 278 (12.7) 22 (16.9) 309 (14.1) 5 (7.0)
Athens 155 (7.1) 27 (20.8) 67 (3.1) 35 (49.3)
Utrecht 398 (18.1) 23 (18.5) 476 (21.8) 4 (5.6)
Lodz 453 (20.6) 6 (4.6) 378 (17.3) 5 (7.0)
Reykjavik 457 (20.8) 12 (9.2) 473 (21.6) 0 (0.0)
Vilnius 151 (6.9) 13 (10.0) NA NA
NA, Not available.
Results presented in n (%) unless otherwise specified. Bold indicates statistical significance (P < .05).
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TABLE E3. Comparison of model III to model III adjusted for comorbid atopy and IS
Variable
Model III Model III D comorbid atopy* Model III D comorbid atopy D IS†
Children Adults Children Adults Children Adults
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Demographic characteristic
Age (y) 1.01 (0.91-1.13) .85 0.97 (0.96-0.98) <.001 1.02 (0.90-1.16) .85 0.97(0.96-0.99) <.001 0.96 (0.84-1.10) .55 0.99 (0.97-1.01) .21
Male sex 1.01 (0.82-1.25) .92 1.39 (1.12-1.73) <.001 1.01 (0.79-1.28) .81 1.45 (1.16-1.81) <.001 0.64 (0.49-0.84) <.001 1.34 (1.01-1.77) .04
High level of educationz 1.02 (0.80-1.29) .88 0.86 (0.67-1.09) .21 1.02 (0.79-1.36) >.99 0.84 (0.65-1.07) .16 0.96 (0.72-1.29) .80 0.76 (0.56-1.04) .09
Gestational age (wk) 0.93 (0.87-0.99) .01 NA NA 0.93 (0.88-0.99) .02 NA NA 0.92 (0.86-0.99) .03 NA NA
Birth length (cm) 1.00 (1.00-1.00) .97 NA NA 1.01 (0.96-1.05) .71 NA NA 1.01 (0.96-1.06) .75 NA NA
Birth weight (g) 1.01 (0.97-1.06) .65 NA NA 1.00 (1.00-1.00) .93 NA NA 1.00 (1.00-1.00) .85 NA NA
Childhood environment
Maternal age (y) 0.99 (0.97-1.01) .33 1.01 (0.99-1.03) .45 0.99 (0.96-1.01) .32 1.01 (0.98-1.03) .50 0.99 (0.96-1.02) .46 1.00 (0.97-1.03) .98
No. of siblings
1 0.86 (0.63-1.18) .28 1.22 (0.75-1.97) .74 0.85 (0.62-1.17) .36 1.38 (0.85-2.23) .50 1.03 (0.70-1.51) .89 0.92 (0.50-1.69) .51
2 1.09 (0.73-1.64) 1.34 (0.78-2.29) 1.06 (0.71-1.59) 1.52 (0.89-2.61) 1.04 (0.63-1.73) 1.25 (0.63-2.47)
3 or more 0.76 (0.40-1.44) 1.35 (0.75-2.42) 0.77 (0.40-1.47) 1.49 (0.83-2.68) 0.80 (0.36-1.76) 1.15 (0.55-2.41)
No. of older siblings
1 0.85 (0.63-1.15) .62 1.17 (0.85-1.62) .75 0.86 (0.64-1.16) .65 1.17 (0.84-1.61) .77 0.89 (0.62-1.28) .70 1.56 (1.04-2.35) .18
2 1.02 (0.63-1.18) 1.21 (0.78-1.88) 1.02 (0.63-1.65) 1.21 (0.78-1.88) 1.21 (0.67-2.18) 1.34 (0.76-2.35)
3 or more 0.77 (0.31-1.95) 1.22 (0.69-2.14) 0.75 (0.29-1.90) 1.20 (0.68-2.11) 1.06 (0.35-3.17) 1.23 (0.60-2.54)
Bedroom sharing with
other children
0.77 (0.53-1.13)x .18 0.84 (0.62-1.14)k .26 0.76 (0.51-1.11)x .15 0.84 (0.62-1.13)k .25 1.02 (0.63-1.63)x .95 0.95 (0.65-1.40)k .79
Bedroom sharing with
older children
1.19 (0.79-1.80)x .40 0.75 (0.52-1.06)k .11 1.21 (0.80-1.83)x .37 0.77 (0.54-1.10)k .14 1.08 (0.65-1.79)x .78 0.76 (0.48-1.19)k .23
Day care attendance 0.82 (0.64-1.05)x .12 1.02 (0.80-1.30)k .89 0.82 (0.64-1.06)x .13 1.01 (0.54-1.10)k .97 0.84 (0.62-1.13)x .24 1.10 (0.80-1.50)k .56
Farm environment 1.06 (0.21-5.36)x .95 0.73 (0.40-1.35)k .32 1.09 (0.21-5.56)x .92 0.75 (0.40-1.39)k .35 1.76 (0.27-11.39)x .55 1.15 (0.53-2.51)k .72
Inner-city environment 0.94 (0.76-1.17)x .60 1.01 (0.79-1.29)k .93 0.96 (0.77-1.19)x .69 0.97 (0.76-1.25)k .84 1.02 (0.79-1.34)x .86 1.09 (0.79-1.50)k .60
Pet dog 0.65 (0.48-0.90) .01 0.94 (0.70-1.27)k .61 0.65 (0.47-0.89)x .01 0.94 (0.74-1.21)k .65 0.81 (0.55-1.18)x .27 1.12 (0.82-1.52)k .48
Pet cat 1.04 (0.77-1.40)x .79 0.87 (0.68-1.10)k .24 1.02 (0.76-1.38)x .89 0.89 (0.70-1.13)k .35 1.26 (0.88-1.80)x .21 1.06 (0.78-1.43)k .71
Serious respiratory tract
infection
1.11 (0.86-1.45)x .42 0.88 (0.62-1.25)k .47 1.10 (0.84-1.43)x .50 0.86 (0.60-1.23)k .40 1.33 (0.96-1.83)x .09 0.90 (0.58-1.41)k .66
Use of antibiotics 1.14 (0.89-1.45)x .29 NA NA 1.10 (0.86-1.40)x .46 NA NA 1.07 (0.79-1.43)x .67 NA NA
Maternal smoking during
pregnancy
0.74 (0.51-1.08) .12 NA NA 0.74 (0.51-1.07) .11 NA NA 0.71 (0.45-1.13) .15 NA NA
Maternal smoking since
birth
1.12 (0.84-1.48) .45 NA NA 1.13 (0.85-1.50) .41 NA NA 1.35 (0.95-1.91) .09 NA NA
Paternal smoking since
kbirth
0.97 (0.77-1.22) .78 NA NA 0.97 (0.77-1.23) .82 NA NA 0.86 (0.65-1.13) .27 NA NA
Reflux medication in last 6
mo



















































Model III Model III D comorbid atopy* Model III D comorbid atopy D IS†
Children Adults Children Adults Children Adults
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Breast-feeding duration
4 mo 1.20 (0.82-1.75) .29 NA NA 1.17 (0.80-1.72) .40 NA NA 1.30 (0.81-2.08) .27 NA NA
4-6 mo 1.20 (0.75-1.94) NA NA 1.19 (0.74-1.93) .28 NA NA 1.28 (0.71-2.31) .61 NA NA
>6 mo 0.91 (0.57-1.46) NA NA 0.89 (0.55-1.42) NA NA 1.11 (0.62-1.97) NA NA
Cow’s milk infant formula 0.85 (0.58-1.24) .39 NA NA 0.83 (0.57-1.21) NA NA 0.77 (0.48-1.23) NA NA
Soy milk infant formula 1.35 (0.89-2.05) .16 NA NA 1.29 (0.84-1.96) .23 NA NA 1.17 (0.69-1.98) .56 NA NA
Hypoallergenic infant
formula
1.51 (1.06-2.15) .02 NA NA 1.44 (1.01-2.05) .04 NA NA 1.27 (0.82-1.96) .29 NA NA
Age start infant formula
0-4 mo 1.02 (0.60-1.72) .33 NA NA 1.05 (0.62-1.77) .31 NA NA 1.31 (0.70-2.48) .59 NA NA
4-6 mo 1.04 (0.60-1.79) NA NA 1.05 (0.61-1.82) NA NA 1.25 (0.64-2.45) NA NA
6-11 mo 1.10 (0.66-1.82) NA NA 1.12 (0.67-1.86) NA NA 1.55 (0.82-2.91) NA NA
11 mo 1.79 (0.94-3.40) NA NA 1.84 (0.97-3.51) NA NA 1.73 (0.78-3.84) NA NA
Age introduction solid
foods
4-6 mo 1.37 (1.00-1.86) .19 NA NA 1.39 (1.02-1.89) .17 NA NA 1.18 (0.81-1.71) .82 NA NA
6-11 mo 1.22 (0.86-1.71) NA NA 1.22 (0.87-1.72) NA NA 1.12 (0.75-1.69) NA NA
11 mo 1.45 (0.93-2.27) NA NA 1.43 (0.92-2.24) NA NA 1.07 (0.61-1.86) NA NA
Adult environment
Smoking NA NA 0.99 (0.79-1.24) .94 NA NA 1.03 (0.82-1.29) .81 NA NA 1.20 (0.90-1.61) .22
Food-related occupation NA NA 0.83 (0.64-1.07) .15 NA NA 0.80 (0.62-1.05) .11 NA NA 0.80 (0.57-1.11) .18
Indigestion medication
currently
Yes, <1/mo NA NA 1.30 (0.85-1.97) .59 NA NA 1.21 (0.79-1.85) .63 NA NA 1.43 (0.84-2.44) .16
Yes, <1/wk NA NA 1.10 (0.46-2.60) NA NA 1.01 (0.42-2.42) NA NA 1.06 (0.35-3.20)
Yes,  1/wk NA NA 0.84 (0.46-1.54) NA NA 0.76 (0.41-1.41) NA NA 1.17 (0.56-2.42)
Other allergy
Comorbid atopy NA NA NA NA 2.02 (1.30-3.15) <.001 3.55 (2.22-5.66) <.001 1.40 (0.85-2.30) .18 1.60 (0.92-2.79) .10
Parental FA NA NA NA NA 1.12 (0.87-1.44) .37 NA NA 0.89 (0.65-1.21) .46 NA NA
Positive serology to pollen NA NA NA NA NA NA NA NA 13.15 (9.92-17.44) <.001 13.10 (9.67-17.74) <.001
Positive serology to HDM
or cat
NA NA NA NA NA NA NA NA 2.79 (2.08-3.74) <.001 5.35 (3.96-7.22) <.001
HDM, House-dust mite; NA, not available.
Bold indicates statistical significance (P < .05). Analyses were adjusted for center. P values for continuous variables (age, gestational age, birth weight, birth length, and maternal age) were based on the 2-sample t test, and those for
categorical variables on the c2 test.
Reference categories: “number of (older) siblings” ¼ 0; “indigestion medication” ¼ no or <1/y; “breast-feeding duration” ¼ never; “age start infant formula” ¼ never; “age introduction solid food ¼ 0-4 mo.
*This model was adjusted for comorbid atopy (asthma, allergic rhinitis, or atopic dermatitis in subject or first-degree family member).
†This model was adjusted for comorbid atopy and IS (specific IgE against birch, grass, mugwort, parietaria, HDM, or cat). All P values for continuous variables (age, gestational age, birth weight, birth length, and maternal age) were based on
the 2-sample t test, and those for categorical variables on the c2 test.
zFor children: high level of education of parents.
xBefore the age of 2 y.








































TABLE E4. Predictors for FS compared with predictors for IS and primary FS
Variable
FS IS Primary FS




(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Demographic characteristic
Age (y) 1.01 (0.91-1.13) .85 0.97 (0.96-0.98) <.001 1.11 (1.00-1.22) .05 0.96 (0.95-0.97) <.001 1.00 (0.88-1.12) .93 0.96 (0.95-0.98) <.001
Male sex 1.01 (0.82-1.25) .92 1.39 (1.12-1.73) <.001 1.62 (1.34-1.96) <.001 1.39 (1.16-1.68) <.001 0.99 (0.79-1.25) .93 1.46 (1.10-1.92) .01
High level of education* 1.02 (0.80-1.29) .88 0.86 (0.67-1.09) .21 1.10 (0.89-1.36) .40 0.99 (0.80-1.22) .932 0.93 (0.72-1.20) .59 0.89 (0.66-1.21) .47
Gestational age (wk) 0.93 (0.87-0.99) .01 NA NA 0.96 (0.91-1.02) .15 NA NA 0.96 (0.90-1.02) .16 NA NA
Birth weight (g) 1.00 (1.00-1.00) .97 NA NA 1.00 (1.00-1.00) .15 NA NA 1.00 (1.00-1.00) .57 NA NA
Birth length (cm) 1.01 (0.97-1.06) .65 NA NA 0.99 (0.97-1.02) .52 NA NA 1.02 (0.97-1.07) .43 NA NA
Childhood environment
Maternal age (y) 0.99 (0.97-1.01) .33 1.01 (0.99-1.03) .45 0.99 (0.97-1.02) .61 1.02 (1.00-1.04) 0.03 0.99 (0.97-1.02) .46 1.01 (0.98-1.04) .66
No. of siblings
1 0.86 (0.63-1.18) .28 1.22 (0.75-1.97) .74 0.87 (0.66-1.16) .16 1.50 (1.01-2.25) .22 0.91 (0.65-1.28) .29 1.20 (0.65-2.23) .78
2 1.09 (0.73-1.64) 1.34 (0.78-2.29) 1.18 (0.82-1.70) 1.37 (0.87-2.16) 1.22 (0.79-1.89) 1.40 (0.70-2.78)
3 or more 0.76 (0.40-1.44) 1.35 (0.75-2.42) 0.93 (0.53-1.63) 1.51 (0.93-2.47) 0.87 (0.43-1.73) 1.30 (0.61-2.79)
No. of older siblings
1 0.85 (0.63-1.15) .62 1.17 (0.85-1.62) .75 0.92 (0.71-1.20) .76 0.85 (0.65-1.12) .63 0.85 (0.61-1.17) .79 1.47 (0.99-2.18) .19
2 1.02 (0.63-1.18) 1.21 (0.78-1.88) 0.81 (0.53-1.26) 0.95 (0.66-1.38) 0.91 (0.54-1.52) 1.22 (0.70-2.13)
3 or more 0.77 (0.31-1.95) 1.22 (0.69-2.14) 0.99 (0.47-2.10) 0.84 (0.53-1.34) 0.90 (0.34-2.35) 1.73 (0.86-3.46)
Bedroom sharing with
other children
0.77 (0.53-1.13)† .18 0.84 (0.62-1.14)z .26 0.66 (0.46-0.95)† .02 0.81 (0.62-1.04)z .10 0.88 (0.59-1.33)† .54 1.03 (0.70-1.50)z .89
Bedroom sharing with
older children
1.19 (0.79-1.80)† .40 0.75 (0.52-1.06)z .11 1.19 (0.81-1.74)† .37 0.86 (0.64-1.16)z .32 1.14 (0.73-1.77)† .56 0.62 (0.41-0.96)z .03
Day care attendance 0.82 (0.64-1.05)† .12 1.02 (0.80-1.30)z .89 0.95 (0.76-1.18)† .63 0.90 (0.73-1.11)z .35 0.88 (0.68-1.15)† .36 0.91 (0.67-1.24)z .57
Farm environment 1.06 (0.21-5.36)† .95 0.73 (0.40-1.35)z .32 0.22 (0.03-1.88)† .17 0.43 (0.25-0.73)z <.001 1.48 (0.30-7.47)† .63 0.90 (0.44-1.84)z .77
Inner-city environment 0.94 (0.76-1.17)† .60 1.01 (0.79-1.29)z .93 0.88 (0.72-1.07)† .20 0.84 (0.68-1.04)z .11 0.96 (0.76-1.22)† .76 1.17 (0.86-1.59)z .32
Pet dog 0.65 (0.48-0.90)† .01 0.94 (0.70-1.27)z .61 0.73 (0.56-0.96)† .02 0.95 (0.77-1.18)z .66 0.68 (0.48-0.96)† .03 1.02 (0.75-1.40)z .88
Pet cat 1.04 (0.77-1.40)† .79 0.87 (0.68-1.10)z .24 0.91 (0.70-1.19)† .50 0.80 (0.65-0.98)z .03 0.98 (0.71-1.36)† .92 1.02 (0.76-1.38)z .88
Serious respiratory tract
infection
1.11 (0.86-1.45)† .42 0.88 (0.62-1.25)z .47 0.81 (0.63-1.03)† .08 0.94 (0.70-1.27)z .71 1.16 (0.87-1.54)† .30 1.37 (0.91-2.05)z .13
Use of antibiotics 1.14 (0.89-1.45)† .29 NA NA 1.08 (0.87-1.35)† .46 NA NA 1.12 (0.86-1.45)† .40 NA NA
Maternal smoking during
pregnancy
0.74 (0.51-1.08) .12 NA NA 0.87 (0.62-1.22) .42 NA NA 0.85 (0.57-1.27) .43 NA NA
Maternal smoking since
birth
1.12 (0.84-1.48) .45 NA NA 0.86 (0.66-1.11) .24 NA NA 1.06 (0.78-1.44) .73 NA NA
Paternal smoking since
birth
0.97 (0.77-1.22) .78 NA NA 1.11 (0.90-1.36) .33 NA NA 0.95 (0.74-1.22) .69 NA NA
Reflux medication in last 6
mo
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(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Adjusted OR
(95% CI) P value
Infant diet
Vitamin D supplementation 1.05 (0.75-1.47)† .77 NA NA 0.95 (0.70-1.29)† .74 NA NA 0.99 (0.69-1.42)† .96 NA NA
Breast-feeding duration
4 mo 1.20 (0.82-1.75) .29 NA NA 1.24 (0.88-1.75) .23 NA NA 1.14 (0.75-1.72) .54 NA NA
4-6 mo 1.20 (0.75-1.94) NA NA 1.43 (0.93-2.21) NA NA 1.34 (0.81-2.23) NA NA
>6 mo 0.91 (0.57-1.46) NA NA 1.10 (0.72-1.68) NA NA 1.06 (0.64-1.75) NA NA
Cow’s milk infant formula 0.85 (0.58-1.24) .39 NA NA 1.08 (0.76-1.53) .68 NA NA 0.94 (0.63-1.42) .78 NA NA
Soy milk infant formula 1.35 (0.89-2.05) .16 NA NA 1.27 (0.86-1.87) .23 NA NA 1.35 (0.86-2.13) .19 NA NA
Hypoallergenic infant
formula
1.51 (1.06-2.15) .02 NA NA 1.62 (1.17-2.25) <.001 NA NA 1.44 (0.98-2.11) .06 NA NA
Age start infant formula
0-4 mo 1.02 (0.60-1.72) .33 NA NA 0.83 (0.52-1.33) .08 NA NA 1.06 (0.61-1.86) .93 NA NA
4-6 mo 1.04 (0.60-1.79) NA NA 0.69 (0.42-1.15) NA NA 1.04 (0.58-1.88) NA NA
6-11 mo 1.10 (0.66-1.82) NA NA 0.70 (0.44-1.10) NA NA 1.10 (0.63-1.90) NA NA
11 mo 1.79 (0.94-3.40) NA NA 1.31 (0.74-2.33) NA NA 1.32 (0.64-2.71) NA NA
Age introduction solid
foods
4-6 mo 1.37 (1.00-1.86) .19 NA NA 1.34 (1.02-1.76) .09 NA NA 1.30 (0.93-1.81) .30 NA NA
6-11 mo 1.22 (0.86-1.71) NA NA 1.23 (0.91-1.66) NA NA 1.16 (0.80-1.68) NA NA
11 mo 1.45 (0.93-2.27) NA NA 1.58 (1.05-2.38) NA NA 1.31 (0.81-2.13) NA NA
Adult environment
Smoking NA NA 0.99 (0.79-1.24) .94 NA NA 0.89 (0.74-1.08) .24 NA NA 1.35 (1.01-1.80) .04
Food-related occupation NA NA 0.83 (0.64-1.07) .15 NA NA 0.97 (0.78-1.21) .80 NA NA 0.77 (0.55-1.08) .13
Indigestion medication
currently
Yes, <1/mo NA NA 1.30 (0.85-1.97) .59 NA NA 1.05 (0.72-1.52) .91 NA NA 1.75 (1.09-2.82) .09
Yes, <1/wk NA NA 1.10 (0.46-2.60) NA NA 1.10 (0.53-2.28) NA NA 1.77 (0.71-4.47)
Yes,  1/wk NA NA 0.84 (0.46-1.54) NA NA 0.87 (0.54-1.40) NA NA 1.21 (0.62-2.35)
NA, Not available.
Bold indicates statistical significance (P < .05). Analyses were adjusted for center. P values for continuous variables (age, gestational age, birth weight, birth length, and maternal age) were based on the 2-sample t test, and those for
categorical variables on the c2 test.
Reference categories: “number of (older) siblings” ¼ 0; “indigestion medication” ¼ no or <1/y; “breast-feeding duration” ¼ never; “age start infant formula” ¼ never; “age introduction solid food ¼ 0-4 mo.
*For children: high level of education of parents.
†Before the age of 2 y.
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